A carregar...
P10.21 2-hydroxyglutarate as a biomarker for IDH mutation in low grade gliomas
Glioma patients continue to carry a very poor prognosis despite maximal therapy. Several genetic alterations are linked with better survival outcome in glioma patients, including mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2). The product of IDH mutation is the chemical 2-hydroxyglutarate (2...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463979/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.339 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|